Cargando…
Anti-Cancer Effect of IN-2001 in MDA-MB-231 Human Breast Cancer
In recent years, inhibition of HDACs has emerged as a potential strategy to reverse aberrant epigenetic changes associated with cancer, and several classes of HDAC inhibitors have been found to have potent and specific anticancer activities in preclinical studies. But their precise mechanism of acti...
Autores principales: | Min, Kyung Nan, Joung, Ki Eun, Kim, Dae-Kee, Sheen, Yhun Yhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794529/ https://www.ncbi.nlm.nih.gov/pubmed/24130929 http://dx.doi.org/10.4062/biomolther.2012.20.3.313 |
Ejemplares similares
-
Anti-Cancer Effect of IN-2001 in T47D Human Breast Cancer
por: Joung, Ki Eun, et al.
Publicado: (2012) -
Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
por: Min, Kyung Nan, et al.
Publicado: (2012) -
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
por: Xie, Jing, et al.
Publicado: (2016) -
Apoptotic effect of tolfenamic acid on MDA-MB-231 breast cancer cells and xenograft tumors
por: Kim, Hyeong-Jin, et al.
Publicado: (2013) -
Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells
por: Lee, Kyu-Shik, et al.
Publicado: (2020)